On Friday, Citius Pharmaceuticals Inc (NASDAQ: CTXR) was 15.15% up from the session before settling in for the closing price of $0.99. A 52-week range for CTXR has been $0.65 – $5.95.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 20.90%. When this article was written, the company’s average yearly earnings per share was at 50.34%. With a float of $17.98 million, this company’s outstanding shares have now reached $18.47 million.
Citius Pharmaceuticals Inc (CTXR) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Citius Pharmaceuticals Inc stocks. The insider ownership of Citius Pharmaceuticals Inc is 2.67%, while institutional ownership is 11.28%.
Citius Pharmaceuticals Inc (CTXR) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -5.8 earnings per share (EPS) during the time that was less than consensus figure (set at -1.5) by -4.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
Citius Pharmaceuticals Inc (NASDAQ: CTXR) Trading Performance Indicators
You can see what Citius Pharmaceuticals Inc (CTXR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.96, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Citius Pharmaceuticals Inc (CTXR)
The latest stats from [Citius Pharmaceuticals Inc, CTXR] show that its last 5-days average volume of 0.52 million was inferior to 1.07 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 32.46%.
During the past 100 days, Citius Pharmaceuticals Inc’s (CTXR) raw stochastic average was set at 14.16%, which indicates a significant decrease from 39.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1176 in the past 14 days, which was lower than the 0.1329 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3104, while its 200-day Moving Average is $1.3145. Now, the first resistance to watch is $1.2166. This is followed by the second major resistance level at $1.2933. The third major resistance level sits at $1.4065. If the price goes on to break the first support level at $1.0267, it is likely to go to the next support level at $0.9135. Assuming the price breaks the second support level, the third support level stands at $0.8368.
Citius Pharmaceuticals Inc (NASDAQ: CTXR) Key Stats
There are 17,012K outstanding shares of the company, which has a market capitalization of 21.06 million. As of now, sales total 0 K while income totals -39,140 K. Its latest quarter income was 0 K while its last quarter net income were -8,790 K.
